SCHEMBL7104022

SCHEMBL7104022

COc1ccc(CNC(=O)c2cc3c(=O)n(C(C)c4c(C(=O)O)cccc4C(C)(C)C)c(=O)[nH]c3cn2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 2/20 0.45
SLC22A8 Q8TCC7 1/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP3A4 P08684 3/20 0.39
CYP2C9 P11712 3/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
CYP2C19 P33261 1/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
EGLN3 Q9H6Z9 1/20 0.39
MAPT P10636 3/20 0.39
ROCK2 O75116 1/20 0.38
ROCK1 Q13464 1/20 0.38
KDR P35968 1/20 0.38
MAPKAPK2 P49137 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6428878 0.82 MMP13 (0.49) MMP13SLC22A8MEN1KMT2ACYP3A4
SCHEMBL6238392 0.82 MMP13 (0.57) MMP13SLC22A8MEN1KMT2ACYP3A4
SCHEMBL6238386 0.79 MMP13 (0.49) MMP13SLC22A8MEN1KMT2ACYP3A4
SCHEMBL6235291 0.77 MMP13 (0.58) MMP13SLC22A8ROCK2
SCHEMBL7104026 0.74 MMP13 (0.48) MMP13SLC22A8CYP3A4CYP2C9ALDH1A1
SCHEMBL6239453 0.70 MEN1 (0.55) MMP13MEN1KMT2AALDH1A1MAPT
SCHEMBL6237471 0.70 PPARG (0.57) MEN1KMT2AMAPTRAB9A
SCHEMBL7019551 0.70 PPARG (0.57) MEN1KMT2AMAPTRAB9A
SCHEMBL6235396 0.70 MEN1 (0.52) MMP13MEN1KMT2ACYP3A4CYP2C9
SCHEMBL6236712 0.70 MEN1 (0.52) MMP13MEN1KMT2ACYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1368324-A1 QUINAZOLINES AS MMP-13 INHIBITORS Warner-Lambert Company LLC (US) 2003-12-10 EP disclosed
WO-2002064572-A1 QUINAZOLINES AS MMP-13 INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2002-08-22 WO disclosed